MAZE position history
The shares of Maze Therapeutics (MAZE) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 373,000 shares, $11M, 0.06% of portfolio, New
- 2026 Q2: 1,107,814 shares, $33M, 0.15% of portfolio, Add +197.0%
- 2026 Q3: 1,107,814 shares, $30M, 0.13% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|